89 related articles for article (PubMed ID: 16722931)
1. Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease.
Vespasiani Gentilucci U; Perrone G; Galati G; D'Avola D; Zardi EM; Rabitti C; Bianchi A; De Dominicis E; Afeltra A; Picardi A
Histopathology; 2006 Jun; 48(7):822-30. PubMed ID: 16722931
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
Lincoln DT; Singal PK; Al-Banaw A
Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
[TBL] [Abstract][Full Text] [Related]
4. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
Bortolami M; Kotsafti A; Cardin R; Farinati F
J Viral Hepat; 2008 Jul; 15(7):515-22. PubMed ID: 18331250
[TBL] [Abstract][Full Text] [Related]
5. [Expression of growth hormone receptor in hepatocellular carcinoma and its significance].
Liu JP; Wang HT; Ou QJ; Lu YT; Lu HP; Gao JH; Chu ZH; Zhao HY
Ai Zheng; 2003 Mar; 22(3):298-301. PubMed ID: 12654191
[TBL] [Abstract][Full Text] [Related]
6. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
[TBL] [Abstract][Full Text] [Related]
7. Identification of c-Yes expression in the nuclei of hepatocellular carcinoma cells: involvement in the early stages of hepatocarcinogenesis.
Nonomura T; Masaki T; Morishita A; Jian G; Uchida N; Himoto T; Izuishi K; Iwama H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2007 Jan; 30(1):105-11. PubMed ID: 17143518
[TBL] [Abstract][Full Text] [Related]
8. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis.
Sasaki A; Ishikawa K; Haraguchi N; Inoue H; Ishio T; Shibata K; Ohta M; Kitano S; Mori M
Ann Surg Oncol; 2007 Mar; 14(3):1191-9. PubMed ID: 17195907
[TBL] [Abstract][Full Text] [Related]
9. Expression of gap junction protein connexin32 in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
Nakashima Y; Ono T; Yamanoi A; El-Assal ON; Kohno H; Nagasue N
J Gastroenterol; 2004 Aug; 39(8):763-8. PubMed ID: 15338370
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2 positivity in B and C hepatitis and hepatocellular carcinomas.
Yildiz L; Baris S; Aydin O; Kefeli M; Kandemir B
Hepatogastroenterology; 2008; 55(88):2207-10. PubMed ID: 19260506
[TBL] [Abstract][Full Text] [Related]
11. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic interleukin-8 production during disease progression of chronic hepatitis C.
Tachibana Y; Nakamoto Y; Mukaida N; Kaneko S
Cancer Lett; 2007 Jun; 251(1):36-42. PubMed ID: 17240051
[TBL] [Abstract][Full Text] [Related]
13. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.
Toyoda H; Kumada T; Kaneoka Y; Murakami Y
J Hepatol; 2008 Jan; 48(1):43-50. PubMed ID: 18023912
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of MT3-MMP in hepatocellular carcinoma correlates with capsular invasion.
Arai I; Nagano H; Kondo M; Yamamoto H; Hiraoka N; Sugita Y; Ota H; Yoshioka S; Nakamura M; Wada H; Damdinsuren B; Kato H; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshita K; Nakamori S; Wakasa K; Sakon M; Monden M
Hepatogastroenterology; 2007; 54(73):167-71. PubMed ID: 17419254
[TBL] [Abstract][Full Text] [Related]
15. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A
J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643
[TBL] [Abstract][Full Text] [Related]
16. [The effects of recombinant human growth hormone on the proliferation of Bel-7402 human hepatic carcinoma cell lines in vitro and its regulation on growth hormone receptors].
Liu JP; Chen T; Chen XX; Ou QJ
Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):1006-9. PubMed ID: 19035204
[TBL] [Abstract][Full Text] [Related]
17. Expression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?
Kara B; Doran F; Kara IO; Akkiz H; Sandikci M
Int J Clin Pract; 2008 Aug; 62(8):1206-11. PubMed ID: 18284441
[TBL] [Abstract][Full Text] [Related]
18. Insulin regulation of growth hormone receptor gene expression. Evidence for a transcriptional mechanism of down-regulation in rat hepatoma cells.
Bennett WL; Ji S; Messina JL
Mol Cell Endocrinol; 2007 Aug; 274(1-2):53-9. PubMed ID: 17658679
[TBL] [Abstract][Full Text] [Related]
19. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
Pekow JR; Bhan AK; Zheng H; Chung RT
Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
[TBL] [Abstract][Full Text] [Related]
20. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
